Session 2
15:10-16:10
Moderator - Nobuyuki Takei
1. Targeting amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas
Shigeo Ohba - Fujita Health University 20 mins
2. Establishment of bithalamic diffuse midline glioma cell line with EGFR duplication
Takeyoshi Eda - Niigata University 10 mins
3. Overcoming resistance to targeted therapy in BRAF V600E-mutant malignant gliomas using a novel compound
Masayasu Okada - Niigata University 10 mins
4. ATR-Chk1 inhibition to overcome chemo- and radio-resistance in refractory medulloblastoma with low expression of SLFN11
Satoshi Nakata - Gunma University 20 mins
Session 3
16:20-17:00
Moderator - Manabu Natsumeda
1. Near-infrared photoimmunotherapy targeting SSTR-2 for malignant meningiomas
Ryosuke Ogura - Niigata University 10 mins
2. Molecular classification of glioblastoma depends on brain aging
Daisuke Yamashita - Ehime University 10 mins
3. Intraoperative integrated diagnostic system for malignant brain tumors to develop future personalized therapy
Kensuke Tateishi - Yokohama City University 20 mins
